Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples